NASDAQ:CTKB Cytek Biosciences Q3 2026 Earnings Report $5.34 -0.04 (-0.74%) Closing price 10/7/2026 04:00 PM EasternExtended Trading$5.40 +0.07 (+1.22%) As of 10/7/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Cytek Biosciences EPS ResultsActual EPSN/AConsensus EPS -$0.07Beat/MissN/AOne Year Ago EPSN/ACytek Biosciences Revenue ResultsActual RevenueN/AExpected Revenue$52.95 millionBeat/MissN/AYoY Revenue GrowthN/ACytek Biosciences Announcement DetailsQuarterQ3 2026Date11/4/2026TimeAfter Market ClosesConference Call DateWednesday, November 4, 2026Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile Cytek Biosciences Earnings HeadlinesCytek Biosciences (NASDAQ:CTKB) Hits New 52-Week High - Should You Buy?October 6 at 11:01 AM | americanbankingnews.comCytek Biosciences Tightens Shareholder Proposal Governance RulesSeptember 29, 2026 | tipranks.comAnthropic’s $40 million midterm moveAnthropic, creator of Claude, has committed $40 million to Public First Action, a nonpartisan group advocating AI safeguards, American leadership, and transparency ahead of the midterms. Alexander Green, Chief Investment Strategist of The Oxford Club, says the move signals Anthropic's shift from a technical story to a political and financial force, especially as IPO talk builds. A publicly accessible vehicle lists Anthropic as its largest holding, alongside Databricks and Anduril, and can be purchased through an ordinary brokerage account. | The Oxford Club (Ad)Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining ProfitabilitySeptember 29, 2026 | insidermonkey.comCytek Biosciences, Inc. Expands Cytek Cloud Digital Ecosystem With New Cloud Analysis ToolSeptember 24, 2026 | marketscreener.comMCytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis ToolSeptember 23, 2026 | globenewswire.comSee More Cytek Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cytek Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cytek Biosciences and other key companies, straight to your email. Email Address About Cytek BiosciencesCytek Biosciences (NASDAQ:CTKB) develops and manufactures cell analysis technologies for research, clinical, and biopharmaceutical applications. The company is best known for its full-spectrum flow cytometry platform, which captures a broader range of fluorescent light signals than conventional flow cytometers and is designed to support the analysis of complex cell populations. Cytek’s product portfolio includes the Aurora and Northern Lights flow cytometers, which are available in configurations intended for a range of laboratory requirements. The company also provides cell-analysis software, fluorescence reagents, panels, and related consumables that support applications such as immunology, oncology, infectious disease research, cell and gene therapy development, and other areas of biomedical research. Founded in 2011 and headquartered in Fremont, California, Cytek serves customers worldwide through direct operations and distribution partners. Its systems are used by academic and government research institutions, pharmaceutical and biotechnology companies, clinical laboratories, and other organizations conducting advanced cell analysis. Cytek became a publicly traded company on the Nasdaq in 2021.View Cytek Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Skydance Just Became a Media Giant—With an $80 Billion Debt LoadPenguin Solutions Is Soaring as AI Memory Demand ExplodesWall Street Is Betting These 3 Beaten-Down Stocks Have More Room to RunLamb Weston’s Turnaround Is Starting to Look RealRPM International’s Dividend King Status Just Got StrongerAI Chip Demand Gives Linde a New Growth CatalystAllient’s Data Center and Defense Momentum Is Raising the Stakes Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.